Phio Pharmaceuticals director Plott buys $17,100 in shares
Phio Pharmaceuticals director Ronald Todd Plott acquired 15,000 shares of the company's common stock on August 19, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The purchase, valued at $17,100, was made at a price of $1.14 per share. Following the transaction, Mr. Plott now directly owns 15,000 shares of Phio Pharmaceuticals common stock.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
